Atossa Therapeutics Investor Presentation 2023

Atossa Therapeutics is a cancer-focused biopharmaceutical company developing innovative proprietary medicines to address unmet oncology needs. As of December 2022, the company held $111M in cash capital with no debt. The presentation outlines the company's clinical development programs and capital structure.